GlassScriptPhysician profile
Barry L Cromer
NPI 1801876115
$4,723.46
in general payments reported to CMS, 2019-2025
24 companies · $373 in 2025
The $373 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2021: $132 · 2022: $3,219 · 2023: $320 · 2024: $244 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rattan and Associates | $1,673.88 | 2022 | |
| Arthrex, INC. | $1,379.68 | 2022 | |
| Djo, LLC | $336.31 | 2019 | |
| Stryker Corporation | $263.30 | 2022-2024 | Aequalis Perform Reversed, Hoffmann |
| Depuy Synthes Sales INC. | $207.83 | 2019-2025 | Dynacord, Truespan Orthocord, Na |
| Vertex Pharmaceuticals Incorporated | $163.63 | 2025 | |
| Abbott Laboratories | $159.03 | 2023-2024 | Proclaim |
| Heron Therapeutics, INC. | $149.66 | 2023-2025 | Zynrelef |
| Smith+Nephew, INC. | $40.09 | 2022-2023 | Grafix Pl, Stravix |
| Horizon Therapeutics Plc | $38.98 | 2022 | |
| Radius Health, INC. | $30.03 | 2021-2024 | Tymlos |
| Zimmer Biomet Holdings, INC. | $29.01 | 2023 | Gps III Platelet Concentration System |
| Bioventus LLC | $28.07 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $27.87 | 2021-2023 | V.A.C. Veraflo, Prevena |
| Kowa Pharmaceuticals America, INC. | $27.34 | 2023 | Seglentis |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $24.85 | 2025 | Euflexxa |
| Pacira Therapeutics, INC. | $20.10 | 2021 | |
| Ermi LLC | $19.64 | 2022 | |
| Orthofix Medical, INC. | $18.56 | 2021 | |
| Davol INC. | $17.98 | 2024 | Arista Ah Flexitip |
| Electronic Waveform Lab, INC. | $17.82 | 2023 | |
| Solventum Corporation | $17.30 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Vericel Corporation | $16.45 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.05 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Cromer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.